substance-abuse

Documents about substance-abuse

• Brief and simultaneous assessment of delay, probability, and joint delay–probability discounting: Initial validation of the three-for-one discounting task in tobacco use [preprint]#421733OSF
• Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)#877275ClinicalTrials.gov
• Hair Testing to Assess Consumption of Illicit Psychotropic Agents and Alcohol by Patients Treated With High-dose Buprenorphine and Methadone. Search for a Pharmacogenetic Contribution to Low Efficacy of Substitution Medications#866219ClinicalTrials.gov
• 42 CFR Part 51d — Mental Health and Substance Abuse Emergency Response Procedures#509897Code of Federal Regulations (eCFR)
• Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection#612174eScholarship
• What Dose of Methamphetamine Do Regular Consumers Use Daily? Estimating Oral Amphetamine Milligram Equivalents#683831eScholarship
• Agency Information Collection Activities: Proposed Collection; Public Comment Request: Information Collection Request Title: SAMHSA Data Security Requirements for Accessing Confidential Data (OMB No. 0930-0396)#512440Federal Register
• Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts#619905eScholarship
• Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA#612123eScholarship
• Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)#854203ClinicalTrials.gov
• Gender differences in the provision of injection initiation assistance: a comparison of three North American settings#634633eScholarship
• The Psychosocial Predictors and Day-Level Correlates of Substance Use Among Participants Recruited via an Online Crowdsourcing Platform in the United States: Daily Diary Study#1038643eScholarship
• Day-level associations of nicotine and cannabis vaping and co-vaping with sleep duration and quality among young adults: A smartphone-based daily diary study#642063eScholarship
• S508 Naloxegol Achieved Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms in Patients With Extreme OIC: A Pooled Analysis of Two Pivotal Phase 3 Trials#683968eScholarship
• 42 CFR Part 54 — Charitable Choice Regulations Applicable to States Receiving Substance Abuse Prevention and Treatment Block Grants and/or Projects for Assistance in Transition from Homelessness Grants#509906Code of Federal Regulations (eCFR)
• Suchtforschungsverbund Bayern/Dresden "Allocating Substance Abuse Treatments to Patient Heterogeneity" (ASAT) : Schlußbericht 2004 ; Zuwendungsempfänger: 1. Technische Universität Dresden, Förderkennzeichen 01 EB 0140, Laufzeit des Vorhabens: 01.11.2001 - 31.10.2004; 2. IFT Institut für Therapieforschung München, Förderkennzeichen 01 EB 0141, Laufzeit des Vorhabens: 01.11.2001 - 31.10.2004; 3. Ludwig-Maximilians-Universität München, Förderkennzeichen: 01 EB 0142, Laufzeit des Vorhabens: 01.06.2002 - 31.10.2004#129694DataCite